ATARA Biotherapeutics (ATRA) Tops Q3 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. SPY
5. META
6. MSFT
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to ATARA Biotherapeutics (ATRA) Tops Q3 EPS by 4c

Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress

November 4, 2021 7:30 AM EDT

Positive Pivotal Phase 3 ALLELE Data Reinforcing the Transformative Potential of Tab-cel® to be Highlighted as Oral Presentation at Upcoming American Society of Hematology Meeting

Significant Tab-cel® Regulatory Progress with Imminent EU MAA Submission and Additional Clarity on FDA Requirements for BLA Submission Planned for Q2 2022

ATA188 Data Demonstrates Durable, Clinically Meaningful Disability Improvement and Possible Remyelination in Patients with Progressive Multiple Sclerosis

Company to Host Live Conference Call and Webcast Today at 8:30 a.m. EDT

SOUTH SAN FRANCISCO, Calif.--(BUSINESS... More